Results 151 to 160 of about 138,250 (315)

SCLEROTIC HYPERPLASIA OF THE PHARYNX AND NASO-PHARYNX. [PDF]

, 1901
A. Brown Kelly
openalex   +1 more source

Wiring cost in the organization of a biological network

, 2005
To find out the role of the wiring cost in the organization of the neural network of the nematode \textit{Caenorhapditis elegans} (\textit{C. elegans}), we build the neuronal map of \textit{C. elegans} based on geometrical positions of neurons and define
Achacoso, Albert, Albert, Barabási, Barabási, Beom Jun Kim, Cancho, Carmichael, Cherniak, Dorogovtsev, Eguíluz, Felleman, Hawoong Jeong, Jeong, Kaiser, Kaiser, Kim, Lewis, Manna, Maslov, Newman, Valverde, Watts, White, Wolpert, Yong-Yeol Ahn, Yook, Zhigulin   +27 more
core   +1 more source

OPERATIVE TREATMENT OF CANCER OF LIPS, TONGUE, FLOOR OF MOUTH, AND PHARYNX [PDF]

, 1895
P. S. CONNER
openalex   +1 more source

First Record of Echinoparyphium recurvatum (Trematoda, Echinostomatidae) in Pakistan with New Avian Definitive Host, Vanellus leucurus

, 2019
Parasitological examinations of White-tailed Lapwing Vanellus leucurus (Charadriiformes: Charadriidae) collected from Dadu district (Sindh Province, Southern Pakistan) were carried out at the Department of Zoology, University of Sindh, Jamshoro.
Birmani, Nadir, Mouahid, Gabriel, Naz, Saima   +2 more
core   +1 more source

Elexacaftor–Tezacaftor–Ivacaftor Improves Sinonasal Outcomes in Young Children With Cystic Fibrosis

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Severe chronic rhinosinusitis (CRS) is a near universal manifestation of cystic fibrosis. Elexacaftor/tezacaftor/ivacaftor (ETI) is an oral, small molecule, highly effective Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) corrector–potentiator drug.
Amanda L. Stapleton, Adam Kimple, Jennifer L. Goralski, Daniel M. Beswick, Anshika Gupta, Douglas A. Li, Barton F. Branstetter, S. Mehdi Nouraie, Amber D. Shaffer, Brent Senior, Anna C. Zemke   +10 more
wiley   +1 more source

XLI. Report of a Case of Sarcoma of the Pharynx [PDF]

, 1919
William C. Bane
openalex   +1 more source

Beyond the Lung. Impact of Elexacaftor/Tezacaftor/Ivacaftor on Sinonasal Disease in Children With Cystic Fibrosis

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Elexacaftor/tezacaftor/ivacaftor (ETI) is a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) therapy that improves pulmonary function and chronic rhinosinusitis (CRS) in cystic fibrosis (CF) adults with at least one copy of the F508del CFTR mutation.
Margaux Petitjean, Alexia Letierce, Anne‐Sophie Bonnel, Philippe Reix, Eric Deneuville, Nathalie Stremler, Romain Luscan, Vincent Couloigner, Laurent Mely, Katia Bessaci, Guillaume Labbe, Christophe Marguet, Mairead Kelly‐Aubert, Fatiha Hassani, Isabelle Sermet‐Gaudelus, François Simon, the MODUL‐CF Study Group   +16 more
wiley   +1 more source

On the Structixre of the Pharynx, Larynx, and Hyoid Bones in the Epomophori; with Remarks on its Relation to the Hahits of these Animals.

, 1881
G. E. Dobson
openalex   +2 more sources

Pharynx [PDF]

, 1913

openalex   +1 more source

Inflammation targets specific organs for cancer in carriers of BRCA1/2 pathway mutations [PDF]

, 2010
Women who inherit a defective BRCA1 or BRCA2 gene have risks for breast/ovarian cancer that are so high and apparently so selective that many mutation carriers choose to have the most likely targets for cancer surgically removed.
Bernard Friedenson
core   +1 more source